Capital Flow Monitor · Sponsors · CIK 2053885
NextEvo, Inc.
181 WASHINGTON STREET, CONSHOHOCKEN, PA, 19428 · 925-200-6766
Pharmaceuticals · Corporation· inc. DELAWARE true
Fit score
—
Offering
—
Sold
$725K
% sold
—
Investors
1
Min investment
$0
Exemption
506(b)
Filing history
| Filed | Form | Rule | Offering | Sold | % sold | Investors | |
|---|---|---|---|---|---|---|---|
| 2026-04-29 | D/A ·current | 506(b) | — | $725K | — | 1 | EDGAR ↗ |
| 2026-02-17 | D/A | 506(b) | — | $600K | — | 1 | EDGAR ↗ |
| 2025-12-17 | D/A | 506(b) | — | $500K | — | 1 | EDGAR ↗ |
Related persons
Executive officers, directors and promoters, as filed. Other raises are matched by exact name and show amount sold as last reported.
- Howard Goodwin — Executive Officer / Director, Conschohocken, PA
- Gerry McNally — Executive Officer, Conshohocken, PA
-
Cornelius Merlini — Director, Conshohocken, PA
1 other raise
- INTRINSIC HEALTH PARTNERS II, L.P. $62.4M of —
- Gerald Stahlecker — Executive Officer / Director, Conshohocken, PA
- Ross Desmarais — Executive Officer / Director, Conshohocken, PA
Placement agents
- No sales compensation reported — direct raise.
Source: SEC EDGAR Form D. Self-reported by the issuer. Not investment advice.